Differences of statin activity in 2D and 3D pancreatic cancer cell cultures

Purpose To evaluate the anticancer activity of lovastatin (LOVA), mevastatin (MEVA), pitavastatin (PITA), and simvastatin (SIMVA) in 2D and 3D models of three human pancreatic cancer cell lines (BxPC-3, MIA PaCa-2, and PANC-1). Methods The effect of statins on cell viability was estimated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test. The activity of statins in 3D pancreatic cancer cell cultures was examined by measuring the size change of spheroids. The type of cell death was identified by cell staining with Hoechst 33342 and propidium iodide. The activity of statins on the clonogenicity of cancer cells was tested by evaluating the effect on the colony-forming ability of cells. Results The rank order of the activity of tested statins on cell viability was as follows: PITA > SIMVA > LOVA > MEVA. Among the tested statins, PITA had the greatest effect on cell viability (half maximal effective concentration values after 72 h on BxPC-3, MIA PaCa-2, and PANC-1 cells were 1.4±0.4 μM, 1.0±0.2 μM, and 1.0±0.5 μM, respectively). PITA also showed the strongest effect on tumor spheroid growth. Statins suppressed the colony formation of cancer cells. PITA demonstrated the greatest reduction in colony size and number. Apoptosis and necrosis assay results showed that at lower concentrations statins mostly induced cell death through apoptosis, whereas higher concentrations of compounds activated also necrotic processes. Conclusion Statins, especially PITA, demonstrate an anticancer activity against pancreatic cancer cell lines BxPC-3, MIA PaCa-2, and PANC-1 in both 2D and 3D models.

• Publication year

  2017

• Venue

  Drug Design, Development and Therapy

• Publication date

  2017-11-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2147/DDDT.S149411PMID 29180851PMCID 5695256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency

  2016influential reference
• Pitavastatin suppressed liver cancer cells in vitro and in vivo

  2016influential reference
• A spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device-based imaging

  2015cited by this paper
• Simvastatin suppresses breast cancer cell proliferation induced by senescent cells

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2015cited by this paper
• A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs

  2015cited by this paper
• Fluvastatin inhibits growth and alters the malignant phenotype of the C6 glioma cell line

  2014cited by this paper
• In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

  2014cited by this paper
• Statins in oncological research: from experimental studies to clinical practice.

  2014cited by this paper
• Preclinical evaluation of statins as a treatment for ovarian cancer.

  2013cited by this paper
• Metrics other than potency reveal systematic variation in responses to cancer drugs.

  2013cited by this paper
• 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing

  2013cited by this paper
• Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.

  2013cited by this paper
• Glycosaminoglycans: key players in cancer cell biology and treatment

  2012cited by this paper
• The differential effects of statins on the metastatic behaviour of prostate cancer

  2012cited by this paper
• Statins and cancer: current and future prospects.

  2012cited by this paper
• Targeting protein prenylation for cancer therapy

  2011cited by this paper
• Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase

  2009cited by this paper
• Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

  2008cited by this paper
• Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis‐associated colon cancer in mice

  2008cited by this paper
• Statin Induces Apoptosis and Cell Growth Arrest in Prostate Cancer Cells

  2008cited by this paper
• Tumor microenvironment: The role of the tumor stroma in cancer

  2007cited by this paper
• Breast cancer growth prevention by statins.

  2006cited by this paper
• Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK

  2005cited by this paper
• Statin inhibition of HMG-CoA reductase: a 3-dimensional view.

  2003cited by this paper
• Pharmacologic characteristics of statins

  2003cited by this paper
• Pharmacology of 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and Pitavastatin

  2002cited by this paper
• Structural Mechanism for Statin Inhibition of HMG-CoA Reductase

  2001cited by this paper
• submit your manuscript | www.dovepress.com

  year unknowncited by this paper

• Pro-Apoptotic Effects of Unsymmetrical Bisacridines in 3D Pancreatic Multicellular Tumor Spheroids

  2025cites this paper
• Enhancing scaffold-free spheroid models: 3D cell bioprinting method for metastatic HSC3-Oral squamous carcinoma cell line.

  2024cites this paper
• Modulation of Epithelial–Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel

  2024cites this paper
• Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells

  2024cites this paper
• Anticancer effects of simvastatin-loaded albumin nanoparticles on monolayer and spheroid models of breast cancer.

  2024cites this paper
• Comprehensive estrogenic/anti-estrogenic, anticancer, mutagenic/anti-mutagenic, and genotoxic/anti-genotoxic activity studies on chemically characterized black poplar and Eurasian aspen propolis types.

  2023cites this paper
• A proteomic signature and potential pharmacological opportunities in the adaptive resistance to MEK and PI3K kinase inhibition in pancreatic cancer cells

  2023cites this paper
• The anti-angiogenic effect of atorvastatin loaded exosomes on glioblastoma tumor cells: An in vitro 3D culture model.

  2022cites this paper
• Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models

  2022influential citation
• Pitavastatin loaded nanoparticles: a suitable ophthalmic treatment for Acanthamoeba Keratitis inducing cell death and autophagy in Acanthamoeba polyphaga.

  2022cites this paper
• Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients

  2022cites this paper
• Implications of Three-Dimensional Cell Culture in Cancer Therapeutic Research

  2022cites this paper
• The Effect of Beta Adrenoreceptor Blockers on Viability and Cell Colony Formation of Non-Small Cell Lung Cancer Cell Lines A549 and H1299

  2022cites this paper
• Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines

  2022cites this paper
• The potential use of simvastatin for cancer treatment: A review.

  2021cites this paper
• Comparison of the Effects of Statins on A549 Nonsmall-Cell Lung Cancer Cell Line Lipids Using Fourier Transform Infrared Spectroscopy: Rosuvastatin Stands Out.

  2021cites this paper
• Applications of Biomaterials in 3D Cell Culture and Contributions of 3D Cell Culture to Drug Development and Basic Biomedical Research

  2021cites this paper
• Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells

  2021cites this paper
• A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway

  2021cites this paper
• A 3D Cell Death Assay to Quantitatively Determine Ferroptosis in Spheroids

  2020cites this paper
• A Novel Ruthenium Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis Via Activating PI3K/Akt/mTOR/VEGF/ MAP Kinase Pathway

  2020cites this paper
• CMAR_A_247876 4645..4665

  2020cites this paper
• OTT_A_283033 13201..13209

  2020cites this paper
• Abstract. Statins, a class of commonly prescribed choles- terol‐lowering medications, have been revealed to influence the risk of multiple types of cancer. However, the antitumor effects of statins on pancreatic cancer and their differential efficacy

  2020cites this paper
• Comparative Study of Lipophilic Statin Activity in 2D and 3D in vitro Models of Human Breast Cancer Cell Lines MDA-MB-231 and MCF-7

  2020cites this paper
• Simvastatin treatment varies the radiation response of human breast cells in 2D or 3D culture

  2020cites this paper
• Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer

  2020cites this paper
• Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models

  2020influential citation
• Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo

  2020cites this paper
• Simvastatin Induces Apoptosis in Medulloblastoma Brain Tumor Cells via Mevalonate Cascade Prenylation Substrates

  2019cites this paper
• Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures

  2019cites this paper
• Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms.

  2019cites this paper
• Briefly about Anticancer Properties of Statins

  2019influential citation